Key Financial Data Of Group

AFC-HD AMS Life Science Co.,Ltd. - Filing #7294071

Concept As at
2024-08-31
As at
2024-08-31
As at
2024-08-31
As at
2024-08-31
As at
2024-08-31
As at
2024-08-31
2023-09-01 to
2024-08-31
As at
2024-08-31
As at
2024-08-31
2023-09-01 to
2024-08-31
As at
2024-08-31
As at
2024-08-31
As at
2023-08-31
As at
2023-08-31
2022-09-01 to
2023-08-31
2022-09-01 to
2023-08-31
2021-09-01 to
2022-08-31
As at
2022-08-31
2021-09-01 to
2022-08-31
As at
2022-08-31
2020-09-01 to
2021-08-31
As at
2021-08-31
As at
2021-08-31
2020-09-01 to
2021-08-31
2019-09-01 to
2020-08-31
As at
2020-08-31
2019-09-01 to
2020-08-31
As at
2020-08-31
Key financial data of group
Business results of group
Net sales
14,081,328,000 JPY
30,185,451,000 JPY
25,579,009,000 JPY
11,932,357,000 JPY
23,024,860,000 JPY
11,624,182,000 JPY
22,368,076,000 JPY
14,370,897,000 JPY
15,819,281,000 JPY
13,095,535,000 JPY
Ordinary profit (loss)
1,364,591,000 JPY
1,921,421,000 JPY
1,654,107,000 JPY
1,273,723,000 JPY
1,343,193,000 JPY
1,045,219,000 JPY
2,161,969,000 JPY
1,165,935,000 JPY
1,099,829,000 JPY
850,727,000 JPY
Profit (loss) attributable to owners of parent
1,252,067,000 JPY
1,102,563,000 JPY
735,353,000 JPY
1,495,554,000 JPY
676,683,000 JPY
Comprehensive income
1,143,852,000 JPY
1,144,223,000 JPY
827,256,000 JPY
1,516,546,000 JPY
705,685,000 JPY
Net assets
11,273,336,000 JPY
13,958,098,000 JPY
13,157,452,000 JPY
10,676,668,000 JPY
10,163,394,000 JPY
12,445,149,000 JPY
12,660,917,000 JPY
10,098,442,000 JPY
10,463,909,000 JPY
9,274,178,000 JPY
Total assets
31,488,150,000 JPY
47,030,684,000 JPY
41,071,748,000 JPY
29,173,363,000 JPY
27,611,664,000 JPY
37,348,660,000 JPY
35,752,403,000 JPY
26,548,392,000 JPY
18,548,888,000 JPY
15,305,528,000 JPY
Net assets per share
800.93
990.10
938.25
764.17
722.39
884.53
833.44
705.25
744.04
659.44
Basic earnings (loss) per share
69.06
89.20
78.51
67.93
52.33
51.55
107.12
62.15
48.12
39.03
Diluted earnings per share
68.99
89.11
78.46
67.88
52.08
51.31
106.30
61.67
Equity-to-asset ratio
0.358 xbrli:pure
0.296 xbrli:pure
0.319 xbrli:pure
0.366 xbrli:pure
0.367 xbrli:pure
0.332 xbrli:pure
0.331 xbrli:pure
0.377 xbrli:pure
0.564 xbrli:pure
0.606 xbrli:pure
Rate of return on equity
0.088 xbrli:pure
0.093 xbrli:pure
0.086 xbrli:pure
0.092 xbrli:pure
0.061 xbrli:pure
0.072 xbrli:pure
0.134 xbrli:pure
0.090 xbrli:pure
0.066 xbrli:pure
0.060 xbrli:pure
Price-earnings ratio
12.1 xbrli:pure
9.3 xbrli:pure
10.1 xbrli:pure
11.3 xbrli:pure
14.7 xbrli:pure
14.9 xbrli:pure
10.7 xbrli:pure
18.5 xbrli:pure
14.0 xbrli:pure
17.3 xbrli:pure
Net cash provided by (used in) operating activities
1,540,093,000 JPY
865,280,000 JPY
1,492,417,000 JPY
2,582,697,000 JPY
1,299,011,000 JPY
Net cash provided by (used in) investing activities
-2,761,467,000 JPY
-1,946,009,000 JPY
-1,077,917,000 JPY
-274,967,000 JPY
-458,718,000 JPY
Net cash provided by (used in) financing activities
2,232,074,000 JPY
1,881,171,000 JPY
1,159,612,000 JPY
2,185,303,000 JPY
-574,936,000 JPY
Cash and cash equivalents
12,070,550,000 JPY
11,062,021,000 JPY
10,257,778,000 JPY
8,667,136,000 JPY
4,170,642,000 JPY
Number of employees
345 xbrli:pure
61 xbrli:pure
139 xbrli:pure
509 xbrli:pure
18 xbrli:pure
112 xbrli:pure
155 xbrli:pure
18 xbrli:pure
363 xbrli:pure
994 xbrli:pure
878 xbrli:pure
330 xbrli:pure
325 xbrli:pure
799 xbrli:pure
793 xbrli:pure
324 xbrli:pure
592 xbrli:pure
346 xbrli:pure
Average number of temporary employees
80 xbrli:pure
20 xbrli:pure
84 xbrli:pure
131 xbrli:pure
xbrli:pure
113 xbrli:pure
137 xbrli:pure
xbrli:pure
80 xbrli:pure
485 xbrli:pure
317 xbrli:pure
80 xbrli:pure
80 xbrli:pure
351 xbrli:pure
339 xbrli:pure
81 xbrli:pure
180 xbrli:pure
82 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.